|
1
|
Danielsen SA, Cekaite L, Ågesen TH, Sveen
A, Nesbakken A, Thiis-Evensen E, Skotheim RI, Lind GE and Lothe RA:
Phospholipase C isozymes are deregulated in colorectal cancer -
insights gained from gene set enrichment analysis of the
transcriptome. PLoS One. 6:e244192011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Helenius A and Aebi M: Roles of N-linked
glycans in the endoplasmic reticulum. Annu Rev Biochem.
73:1019–1049. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sakurai J, Nagahama M and Oda M:
Clostridium perfringens alpha-toxin: Characterization and mode of
action. J Biochem. 136:569–574. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kadamur G and Ross EM: Mammalian
phospholipase C. Annu Rev Physiol. 75:127–154. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hicks SN, Jezyk MR, Gershburg S, Seifert
JP, Harden TK and Sondek J: General and versatile autoinhibition of
PLC isozymes. Mol Cell. 31:383–394. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rebecchi MJ and Pentyala SN: Structure,
function, and control of phosphoinositide-specific phospholipase C.
Physiol Rev. 80:1291–1335. 2000.PubMed/NCBI
|
|
7
|
Park JB, Lee CS, Jang JH, Ghim J, Kim YJ,
You S, Hwang D, Suh PG and Ryu SH: Phospholipase signalling
networks in cancer. Nat Rev Cancer. 12:782–792. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sala G, Dituri F, Raimondi C, Previdi S,
Maffucci T, Mazzoletti M, Rossi C, Iezzi M, Lattanzio R, Piantelli
M, et al: Phospholipase Cgamma1 is required for metastasis
development and progression. Cancer Res. 68:10187–10196. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Thomas SM, Coppelli FM, Wells A, Gooding
WE, Song J, Kassis J, Drenning SD and Grandis JR: Epidermal growth
factor receptor-stimulated activation of phospholipase Cgamma-1
promotes invasion of head and neck squamous cell carcinoma. Cancer
Res. 63:5629–5635. 2003.PubMed/NCBI
|
|
10
|
Bertagnolo V, Benedusi M, Brugnoli F,
Lanuti P, Marchisio M, Querzoli P and Capitani S: Phospholipase
C-beta 2 promotes mitosis and migration of human breast
cancer-derived cells. Carcinogenesis. 28:1638–1645. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bertagnolo V, Benedusi M, Querzoli P,
Pedriali M, Magri E, Brugnoli F and Capitani S: PLC-β2 is highly
expressed in breast cancer and is associated with a poor outcome: A
study on tissue microarrays. Int J Oncol. 28:863–872.
2006.PubMed/NCBI
|
|
12
|
Kim MJ, Chang JS, Park SK, Hwang JI, Ryu
SH and Suh PG: Direct interaction of SOS1 Ras exchange protein with
the SH3 domain of phospholipase C-gamma1. Biochemistry.
39:8674–8682. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kelley GG, Reks SE, Ondrako JM and Smrcka
AV: Phospholipase C(epsilon): A novel Ras effector. EMBO J.
20:743–754. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bunney TD, Harris R, Gandarillas NL,
Josephs MB, Roe SM, Sorli SC, Paterson HF, Rodrigues-Lima F,
Esposito D, Ponting CP, et al: Structural and mechanistic insights
into ras association domains of phospholipase C epsilon. Mol Cell.
21:495–507. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Follo MY, Finelli C, Clissa C, Mongiorgi
S, Bosi C, Martinelli G, Baccarani M, Manzoli L, Martelli AM and
Cocco L: Phosphoinositide-phospholipase C β1 mono-allelic deletion
is associated with myelodysplastic syndromes evolution into acute
myeloid leukemia. J Clin Oncol. 27:782–790. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fu L, Qin YR, Xie D, Hu L, Kwong DL,
Srivastava G, Tsao SW and Guan XY: Characterization of a novel
tumor-suppressor gene PLC delta 1 at 3p22 in esophageal squamous
cell carcinoma. Cancer Res. 67:10720–10726. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jones NP and Katan M: Role of
phospholipase Cgamma1 in cell spreading requires association with a
beta-Pix/GIT1-containing complex, leading to activation of Cdc42
and Rac1. Mol Cell Biol. 27:5790–5805. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Piccolo E, Innominato PF, Mariggio MA,
Maffucci T, Iacobelli S and Falasca M: The mechanism involved in
the regulation of phospholipase Cgamma1 activity in cell migration.
Oncogene. 21:6520–6529. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Katterle Y, Brandt BH, Dowdy SF, Niggemann
B, Zänker KS and Dittmar T: Antitumour effects of
PLC-gamma1-(SH2)2-TAT fusion proteins on EGFR/c-erbB-2-positive
breast cancer cells. Br J Cancer. 90:230–235. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Leung DW, Tompkins C, Brewer J, Ball A,
Coon M, Morris V, Waggoner D and Singer JW: Phospholipase C delta-4
overexpression upregulates ErbB1/2 expression, Erk signaling
pathway, and proliferation in MCF-7 cells. Mol Cancer. 3:152004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lattanzio R, Piantelli M and Falasca M:
Role of phospholipase C in cell invasion and metastasis. Adv Biol
Regul. 53:309–318. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Preston-Martin S, Pike MC, Ross RK, Jones
PA and Henderson BE: Increased cell division as a cause of human
cancer. Cancer Res. 50:7415–7421. 1990.PubMed/NCBI
|
|
23
|
Wiseman BS and Werb Z: Stromal effects on
mammary gland development and breast cancer. Science.
296:1046–1049. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mobbs CV, Kaplitt M, Kow LM and Pfaff DW:
PLC-alpha: A common mediator of the action of estrogen and other
hormones? Mol Cell Endocrinol. 80:C187–C191. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schmid P, Wischnewsky MB, Sezer O, Böhm R
and Possinger K: Prediction of response to hormonal treatment in
metastatic breast cancer. Oncology. 63:309–316. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu D, Tan Y, Yang X, Qiao J, Yu C, Wang
L, Li J, Zhang Z and Zhong L: Phospholipase C gamma 1 is a
potential prognostic biomarker for patients with locally advanced
and resectable oral squamous cell carcinoma. Int J Oral Maxillofac
Surg. 43:1418–1426. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Salgia R: Role of c-Met in cancer:
Emphasis on lung cancer. Semin Oncol. 36 Suppl 1:S52–S58. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cuccuru G, Lanzi C, Cassinelli G, Pratesi
G, Tortoreto M, Petrangolini G, Seregni E, Martinetti A, Laccabue
D, Zanchi C, et al: Cellular effects and antitumor activity of RET
inhibitor RPI-1 on MEN2A-associated medullary thyroid carcinoma. J
Natl Cancer Inst. 96:1006–1014. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
McCubrey JA, Steelman LS, Chappell WH,
Abrams SL, Wong EW, Chang F, Lehmann B, Terrian DM, Milella M,
Tafuri A, et al: Roles of the Raf/MEK/ERK pathway in cell growth,
malignant transformation and drug resistance. Biochim Biophys Acta.
1773:1263–1284. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kassis J, Moellinger J, Lo H, Greenberg
NM, Kim HG and Wells A: A role for phospholipase C-gamma-mediated
signaling in tumor cell invasion. Clin Cancer Res. 5:2251–2260.
1999.PubMed/NCBI
|
